- Volatile Sedation for Patients With the Acute Respiratory Distress Syndrome — Recruiting • Phase II • Respiratory / COPD / Asthma • NCT06014138.
- What is being tested: The trial compares volatile anaesthetic sedation against conventional intravenous sedation approaches in mechanically ventilated ICU patients to evaluate effects on respiratory function and clinical outcomes.
- Patient eligibility overview: The study enrolls critically ill patients requiring mechanical ventilation and sedation in the ICU; specific inclusion/exclusion criteria would determine suitability based on underlying condition severity and contraindications.
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
This study will investigate how different types of routine sedation may affect patient's breathing whilst on a ventilator in the Intensive Care Unit (ICU). There are different approaches to sedation which may have advantages and disadvantages. During the study patients will receive both intravenous and inhaled volatile sedation (similar to anaesthetic 'gases' used for general anaesthesia) and the drive to breath, breathing efforts and function of the lung will be assessed.
- : * Adult patients admitted to the Intensive Care Unit (ICU) * ARDS * Invasive mechanical ventilation (IMV) * Spontaneous breathing in pressures support mode (PSV) for less than or equal to 48 hours * Sedated with intravenous sedation (ie. propofol and / or midazolam and fentanyl or alternate short acting opioid) * Anticipated to remain on IMV and PSV and with a stable sedation score for a further 24 hours without planned sedation interruption / spontaneous breathing trial or other significant change in the level of ventilator support * Not receiving / anticipated to receive paralysis * In supine position
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.